1National Health (Pharmaceutical Benefits Scheme- class of pharmaceutical items – Subsection 99ACA(3) Determination 2017

Image unavailable in extracted text

PB 82 of 2017

National Health (Pharmaceutical Benefits Scheme- class of pharmaceutical items - Subsection 99ACA(3)) Determination 2017

National Health Act 1953

I, LISA LA RANCE, Assistant Secretary, Pricing and Policy Branch, Technology Assessment and Access Division, Department of Health, delegate of the Minister for Health, make this Determination under subsection 99ACA(3) of the National Health Act 1953.

Dated 19 September 2017

LISA LA RANCE

Assistant Secretary

Pricing and Policy Branch

Technology Assessment and Access Division

Department of Health

1 Name of Instrument

(1) This instrument is the National Health (Pharmaceutical Benefits Scheme- class of pharmaceutical items – Subsection 99ACA(3) Determination 2017.

(2) This instrument may also be cited as PB 82 of 2017.

2 Commencement

This instrument commences on the date of registration on the Federal Register of Legislation.

3 Revocation

The Determination under subsection 99ACA(3) of the National Health Act 1953 (PB 59 of 2007) is revoked.

4 Authority

This Determination is made under subsection 99ACA (3) of the National Health Act 1953.

5 Definitions

In this Determination:

Administrative price reduction means a non-statutory price reduction that has been agreed under section 85AD of the Act.

Note: Terms used in this Determination have the same meaning as in the Act – see section 13 of the Legislation Act 2003. These terms include:

• pharmaceutical item
• listed component drug
• manner of administration

6 Class of pharmaceutical items

The class of pharmaceutical items identified in the Schedule, by listed component drug and manner of administration, have taken a 12.5% administrative price reduction.

Schedule